JULIE SHAFFER: Open Payments
NPI 1144989443 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,731 in 160 payments from 14 companies in 2025. Trend: 2023 $2,024 · 2024 $2,864 · 2025 $2,731
Food & beverage: $2,646Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 82 | $1,107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $452 |
| Janssen Biotech, Inc. | 21 | $399 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $137 |
| GENZYME CORPORATION | 5 | $137 |
| Gilead Sciences, Inc. | 6 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $98 |
| Ardelyx, Inc. | 4 | $74 |
| Lilly USA, LLC | 3 | $63 |
| QOL Medical, LLC | 2 | $37 |
Products named: RINVOQ, TREMFYA, ENTYVIO, DUPIXENT, CREON, LINZESS, EOHILIA, XIFAXAN.
Industry payments across IN — which companies pay providers there.
